Aquestive Therapeutics, Inc. (AQST) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $126.00K; Additional Paid in CapitalUSD $421.21M; Retained Earnings (Accumulated Deficit)USD $-477.92M; Stockholders' Equity Attributable to ParentUSD $-56.59M.
- 2026-03-31: Common Stock, Value, IssuedUSD $124.00K; Additional Paid in CapitalUSD $420.88M; Retained Earnings (Accumulated Deficit)USD $-455.06M; Stockholders' Equity Attributable to ParentUSD $-34.05M.
- 2025-12-31: Common Stock, Value, IssuedUSD $122.00K; Additional Paid in CapitalUSD $413.21M; Retained Earnings (Accumulated Deficit)USD $-447.00M; Stockholders' Equity Attributable to ParentUSD $-33.66M.
- 2025-09-30: Common Stock, Value, IssuedUSD $121.00K; Additional Paid in CapitalUSD $410.91M; Retained Earnings (Accumulated Deficit)USD $-415.14M; Stockholders' Equity Attributable to ParentUSD $-4.11M.
Aquestive Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD | Partners' Capital Account, Units shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $126.00K | $421.21M | $-477.92M | $-56.59M | (m) | (m) | 3 month · $2.88M | 3 month · $663.00K | (m) | (m) |
| 2026-03-31 | $124.00K | $420.88M | $-455.06M | $-34.05M | (m) | (m) | 3 month · $2.32M | (m) | (m) | (m) |
| 2025-12-31 | $122.00K | $413.21M | $-447.00M | $-33.66M | (m) | (m) | 12 month · $7.54M | (m) | (m) | (m) |
| 2025-09-30 | $121.00K | $410.91M | $-415.14M | $-4.11M | (m) | 3 month · $-72.00K | 3 month · $2.78M | (m) | (m) | (m) |
| 2025-06-30 | $99.00K | $327.00M | $-399.69M | $-72.59M | 3 month · $34.00K | 3 month · $-19.00K | 3 month · $1.88M | (m) | (m) | (m) |
| 2025-03-31 | $99.00K | $325.12M | $-386.14M | $-60.93M | (m) | 3 month · $-702.00K | 3 month · $1.59M | (m) | (m) | (m) |
| 2024-12-31 | $91.00K | $302.97M | $-363.21M | $-60.16M | (m) | 12 month · $-1.35M | 12 month · $7.06M | (m) | (m) | (m) |
| 2024-09-30 | $91.00K | $300.65M | $-346.16M | $-45.42M | (m) | 3 month · $-202.00K | 3 month · $1.58M | (m) | (m) | (m) |
| 2024-06-30 | $91.00K | $299.08M | $-334.65M | $-35.48M | (m) | 3 month · $-5.00K | 3 month · $1.52M | (m) | (m) | (m) |
| 2024-03-31 | $90.00K | $295.51M | $-331.90M | $-36.30M | (m) | 3 month · $-893.00K | 3 month · $1.58M | (m) | (m) | (m) |
| 2023-12-31 | $69.00K | $212.52M | $-319.08M | $-106.49M | (m) | 12 month · $2.66M | 12 month · $-11.00K | (m) | 12 month · $-552.00K | (m) |
| 2023-09-30 | $67.00K | $207.97M | $-310.97M | $-102.93M | (m) | (m) | 3 month · $774.00K | (m) | (m) | (m) |
| 2023-06-30 | $62.00K | $202.22M | $-308.93M | $-106.65M | 3 month · $235.00K | 3 month · $-3.00K | 3 month · $631.00K | (m) | (m) | (m) |
| 2023-03-31 | $56.00K | $193.85M | $-303.14M | $-109.23M | 3 month · $77.00K | 3 month · $-8.00K | 3 month · $344.00K | (m) | (m) | (m) |
| 2022-12-31 | $55.00K | $192.60M | $-311.21M | $-118.55M | (m) | 12 month · $-3.00K | 12 month · $4.37M | (m) | 12 month · $-289.00K | (m) |
| 2022-09-30 | $54.00K | $190.98M | $-298.86M | $-107.82M | (m) | 3 month · $-3.00K | 3 month · $535.00K | (m) | 3 month · $-98.00K | (m) |
| 2022-06-30 | $53.00K | $189.91M | $-286.32M | $-96.36M | (m) | (m) | 3 month · $2.22M | 3 month · $5.87M | (m) | (m) |
| 2022-03-31 | $41.00K | $176.83M | $-270.02M | $-93.14M | (m) | (m) | 3 month · $913.00K | (m) | 3 month · $-62.00K | (m) |
| 2021-12-31 | $41.00K | $174.62M | $-256.80M | $-82.13M | (m) | 12 month · $-14.00K | 12 month · $6.79M | (m) | 12 month · $-1.29M | (m) |
| 2021-09-30 | $40.00K | $167.47M | $-227.85M | $-60.34M | (m) | 3 month · $-9.00K | 3 month · $1.90M | (m) | 3 month · $-135.00K | (m) |
| 2021-06-30 | $39.00K | $159.49M | $-213.30M | $-53.77M | (m) | 3 month · $-4.00K | 3 month · $1.71M | (m) | 3 month · $-627.00K | (m) |
| 2021-03-31 | $36.00K | $149.09M | $-200.93M | $-51.80M | 3 month · $306.00K | (m) | 3 month · $1.51M | (m) | 3 month · $-306.00K | (m) |
| 2020-12-31 | $35.00K | $137.72M | $-186.26M | $-48.50M | 12 month · $473.00K | 12 month · $-99.00K | 12 month · $6.56M | 12 month · $735.00K | 12 month · $-473.00K | (m) |
| 2020-09-30 | $34.00K | $129.34M | $-165.89M | $-36.52M | (m) | (m) | 3 month · $1.42M | (m) | (m) | (m) |
| 2020-06-30 | $34.00K | $127.92M | $-149.34M | $-21.39M | (m) | 3 month · $-52.00K | 3 month · $1.75M | (m) | (m) | (m) |
| 2020-03-31 | $34.00K | $126.14M | $-147.00M | $-20.83M | (m) | 3 month · $-37.00K | 3 month · $1.86M | (m) | (m) | (m) |
| 2019-12-31 | $34.00K | $124.32M | $-130.47M | $-6.12M | (m) | (m) | 12 month · $7.04M | 12 month · $6.80M | 12 month · $-540.00K | (m) |
| 2019-09-30 | $25.00K | $83.35M | $-117.84M | $-34.46M | (m) | (m) | 3 month · $1.81M | 3 month · $6.80M | (m) | (m) |
| 2019-06-30 | $25.00K | $74.74M | $-99.43M | $-24.66M | (m) | (m) | 3 month · $1.74M | (m) | (m) | (m) |
| 2019-03-31 | $25.00K | $72.87M | $-78.95M | $-6.06M | (m) | (m) | 3 month · $1.42M | (m) | (m) | (m) |
| 2018-12-31 | $25.00K | $71.43M | $-61.38M | $10.08M | 12 month · $5.23M | (m) | 12 month · $2.28M | 12 month · $116.00K | (m) | (m) |
| 2018-09-30 | $25.00K | $70.85M | $-47.43M | $23.44M | 3 month · $5.23M | (m) | 3 month · $995.00K | (m) | (m) | (m) |
| 2018-06-30 | $20.00K | $-6.57M | $-32.39M | $-38.95M | (m) | (m) | 3 month · $7.00K | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $-22.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $0.00 | $-120.09M | $-26.50M | (m) | (m) | (m) | (m) | (m) | 246.77M |
| 2016-12-31 | (m) | (m) | (m) | $-57.20M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |